[Click eStock] "Somagen, Emerging as a Microbiome Service Provider"

[Asia Economy Reporter Jihwan Park] Shinhan Financial Investment evaluated on the 23rd that Somagen(Reg.S) is emerging as a microbiome service company. Microbiome refers to the entire genetic information of microorganisms present in a specific environment or the microorganisms themselves.

Donggeon Lee, Senior Researcher at Shinhan Financial Investment, stated, "Somagen is expected to actively enter the microbiome market based on over 200 microbiome-related patents and approximately 300,000 genomic data secured through the acquisition of the U.S. microbiome analysis service company uBiome."

Somagen is a genome analysis specialized company established in 2004. Based on genome analysis technology, it provides genome analysis services and DTC and microbiome analysis services based on big data secured through these services. Currently, Somagen sells NGS-based microbiome DTC test services mainly through online channels including Amazon.

The researcher forecasted, "Based on the patents and big data secured through the acquisition of uBiome, product launches are expected through hospital-linked clinical diagnostics and partnerships with global health functional food and cosmetics companies." Based on the expansion of the microbiome business, microbiome-related sales are projected to reach 56 billion KRW in 2024.